Urgent off-pump coronary artery bypass grafting in a patient with HIV

Mitsuhiro Kawata1, Kazuhiko Higuchi, Kenji Koseni

  • 1Department of Cardiac Surgery, Asahi General Hospital, Asahi City, Chiba, Japan. mkawata-ths@umin.ac.jp

Insights

Urgent off-pump coronary artery bypass grafting (CABG) is safe for patients with human immunodeficiency virus (HIV). This procedure did not negatively impact CD4+ cell counts or HIV viral load in a recent case study.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Surgical Innovation

Background:

  • Coronary artery disease (CAD) is a significant concern in patients with human immunodeficiency virus (HIV).
  • Off-pump coronary artery bypass grafting (CABG) offers a potential alternative to traditional CABG, especially in high-risk populations.
  • The safety and impact of off-pump CABG on HIV disease progression require careful evaluation.

Observation:

  • A 54-year-old patient with unstable angina pectoris and HIV infection underwent urgent off-pump CABG.
  • Perioperative monitoring included CD4+ cell counts and HIV-RNA viral load.
  • The patient experienced a successful surgical outcome.

Findings:

  • Off-pump CABG did not lead to a decrease in CD4+ cell count.
  • The procedure did not adversely affect the patient's HIV infection status.
  • Surgical recovery was uneventful, with stable immunological markers.

Implications:

  • Off-pump CABG can be considered a viable and safe surgical option for HIV-infected patients with severe coronary artery disease.
  • This approach may help preserve immune function in HIV patients undergoing cardiac surgery.
  • Further research is warranted to confirm these findings in larger cohorts and explore long-term outcomes.